Among them, 41 had chronic inflammatory demyelinating polyneuropathy (CIDP), 4 GBS, 13 vasculitic PN, 6 multifocal motor neuropathy (MMN), 4 anti‐MAG neuropathy, 36 transthyretin‐related conditions (33 TTRv, 3 TTRwt, of whom 14 were asymptomatic carriers), 13 Charcot–Marie–Tooth disease (CMT), 5 idiopathic PN, 1 Fabry with SFN, 1 diabetic PN, 2 chemotherapy‐induced PN, 1 PN and MGUS, and 1 polyneuropathy, organomegaly, endocrinopathy, M‐protein and skin changes (POEMS). This evidence concerns the gene MYOM2 and Guillain-Barre syndrome.